---
title: "Metformin eGFR Dosing Thresholds by Kidney Function"
description: "Metformin eGFR rules from the label: contraindicated below 30, starting not recommended at 30 to 45, and benefit-risk review if eGFR falls below 45."
url: https://healthrx.com/metformin/renal-impairment
publisher: HealthRX.com
---


HealthRX.com

Metformin is contraindicated when eGFR falls below 30

[Print or save as PDF](https://healthrx.com/printables/metformin/renal-impairment?print=1)

Key numbers

- 30 mL/min/1.73 m2 eGFR below which metformin is contraindicated Source: [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2387a618-24d8-4813-aa83-9114edb35374), as cited Nov 8, 2026
- 2,550 mg per day Labeled daily maximum for immediate-release metformin tablets in adults Source: [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2387a618-24d8-4813-aa83-9114edb35374), as cited Nov 8, 2026
- 7% Share of patients with subnormal vitamin B12 in clinical trials Source: [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2387a618-24d8-4813-aa83-9114edb35374), as cited Nov 8, 2026
- 30 and 60 mL/min/1.73 m2 eGFR range where metformin must be stopped before iodinated contrast imaging Source: [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2387a618-24d8-4813-aa83-9114edb35374), as cited Nov 8, 2026

From the public record

Metformin in kidney impairment: a short registry list

Only 19 registered metformin studies list renal impairment, and 8 of them are phase 2. Just 1 is phase 4 and 5 are phase 3, so little of the list is late-stage work. Completed studies number 10, and recruiting ones 2.

Metformin in kidney impairment: a short registry list: the figures

| Measure | Value |
| --- | --- |
| Registered studies | 19 |
| Recruiting now | 2 |
| Not yet recruiting | 0 |
| Completed | 10 |
| Terminated, withdrawn or suspended | 1 |
| Phase 3 (including phase 2/3) | 5 |
| Phase 2 (including phase 1/2) | 8 |
| Phase 1 | 1 |

Source: [NIH National Library of Medicine, ClinicalTrials.gov](https://clinicaltrials.gov/search?intr=metformin&cond=renal%20impairment), data as of Nov 11, 2026

How this was calculated

ClinicalTrials.gov search pairing metformin as the intervention with renal impairment as the condition; the 19 matches were tallied by status and by phase.

Scope: Metformin studies listing renal impairment as a condition

With 19 studies each one moves the totals noticeably, and the condition field does not say which eGFR range was enrolled, the question this page turns on.

[See the public record for Metformin](https://healthrx.com/data/metformin)

HealthRX.com quick answer. The metformin label sets dosing by eGFR, not serum creatinine [1]. It is contraindicated below 30 mL/min/1.73 m2, and should be stopped if eGFR falls below 30 [1]. Starting it at 30 to 45 is not recommended [1]. If eGFR falls below 45 on treatment, assess the benefit and risk of continuing [1]. At 45 or higher, no dose change is specified; check eGFR before starting and at least yearly [1].

At a glance

- eGFR before starting / required by the label [1]
- Routine eGFR on treatment / at least annually, more often in people at risk of kidney decline [1]
- eGFR below 30 / contraindicated, and discontinued if eGFR falls below 30 [1]
- eGFR 30 to 45 / initiation not recommended [1]
- eGFR falls below 45 while taking it / assess benefit and risk of continuing [1]
- Contrast imaging / stop at eGFR 30 to 60, or with liver disease, alcoholism, heart failure, or intra-arterial contrast [1]
- Labeled maximum / 2,550 mg per day immediate-release in adults; 2,000 mg once daily extended-release [1][2]

## The three eGFR zones in the metformin label

The immediate-release and extended-release [metformin](https://healthrx.com/products/metformin) labels use the same renal cutoffs, and both are written in eGFR in mL/min/1.73 m2 rather than a serum creatinine number [1][2].

- **eGFR 45 or higher.** The label's renal section does not specify a dose change here. It asks that eGFR be obtained before starting and at least annually in all patients, and more often in those at risk of kidney decline, such as [older adults](https://healthrx.com/metformin/older-adult-dosing) [1].
- **eGFR 30 to 45.** Initiation of metformin is not recommended in this range [1].
- **eGFR falling below 45 on treatment.** The label directs an assessment of the benefit and risk of continuing therapy [1].
- **eGFR below 30.** Contraindicated. The label directs [discontinuation](https://healthrx.com/metformin/discontinuation-protocol) if eGFR later falls below 30 [1].

Severe renal impairment is one of three contraindications in the label, alongside hypersensitivity to metformin and acute or chronic metabolic acidosis, including diabetic ketoacidosis with or without coma [1].

What people on Reddit report

Accounts from people on metformin who have kidney function concerns, including a CKD diagnosis, dose reductions and questions about whether the drug affects the kidneys.

temperedolive · diabetes

Met is cleared in the kidneys and once you enter CKD3a, your kidneys can't effectively clear it. If it accumulates in the blood, you run a greater risk of lactic acidosis.

A commenter says kidneys that cannot clear metformin in later CKD raise lactic acidosis risk, and advises asking a doctor about a dose change.

[Read the source discussion](https://www.reddit.com/r/diabetes/comments/1t1f3fa/chronic_kidney_disease_and_metformin/)

RiseDelicious3556 · diabetes_t2

An EGFR above 49 is adequate for taking the maximum daily dosage of Metformin per day.

The poster says a higher kidney filtration result allowed the full daily dose, and that metformin does not cause kidney disease.

[Read the source discussion](https://www.reddit.com/r/diabetes_t2/comments/1qgvsum/metformin_does_not_cause_kidney_disease/)

Questions worth asking

Choose the questions you want to keep At what eGFR would my prescriber stop metformin? Has my eGFR been checked in the last year while on metformin? Should I ask about a dose change if my kidney function is lower? What symptoms of lactic acidosis should I watch for on metformin? Are there other tests my prescriber should run while I take metformin?

## Is there a lower dose for eGFR 30 to 45?

The label does not attach a reduced milligram ceiling to the 30 to 45 range. That section addresses whether to start and whether to continue, not a lower target dose [1]. The labeled maxima stay as written: 2,550 mg per day for immediate-release tablets in adults, given in divided doses, and 2,000 mg once daily for extended-release tablets [1][2]. Immediate-release is titrated up by 500 mg weekly or 850 mg every two weeks; extended-release by 500 mg weekly, swallowed whole and never crushed, cut or chewed [1][2].

## Why the label uses eGFR

Metformin is not metabolized, is negligibly bound to plasma proteins, and is cleared by the kidneys [1]. The label describes renal clearance of roughly 3.5 times creatinine clearance, with about 90% of an absorbed dose cleared within 24 hours, and states that [half-life](https://healthrx.com/metformin/pharmacokinetics) lengthens and clearance falls in renal impairment [1].

The label says the risk of metformin accumulation and of metformin-associated lactic acidosis increases with the severity of renal impairment because metformin is substantially excreted by the kidney, and that postmarketing cases occurred primarily in patients with significant renal impairment [1]. It also notes that metformin decreases liver uptake of lactate, raising blood lactate levels, which may increase the risk of lactic acidosis in patients already at risk [1].

## Lactic acidosis: what the label warns

The boxed warning describes postmarketing cases of metformin-associated lactic acidosis that resulted in death, hypothermia, hypotension and resistant bradyarrhythmias [1]. Onset is often subtle, with malaise, myalgias, respiratory distress, somnolence and abdominal pain [1]. The laboratory picture is blood lactate above 5 mmol/L, anion gap acidosis without ketonuria or ketonemia, a raised lactate-to-pyruvate ratio, and metformin plasma levels generally above 5 mcg/mL [1].

The label lists renal impairment, certain drugs such as carbonic anhydrase inhibitors, age 65 or older, radiologic contrast studies, surgery and other procedures, hypoxic states such as acute congestive heart failure, excessive alcohol intake, [hepatic impairment](https://healthrx.com/metformin/hepatic-impairment) and mitochondrial disease as risk factors [1]. If lactic acidosis is suspected, the label directs immediate discontinuation and general supportive measures in a hospital setting, and recommends prompt hemodialysis; it notes metformin is dialyzable with a clearance of up to 170 mL/min under good hemodynamic conditions [1].

How often this happens is hard to pin down. In a UK primary-care cohort of 223,968 metformin users and 34,571 people with diabetes who had never used metformin, the crude incidence of lactic acidosis or a recorded lactate above 5 mmol/L was 7.4 versus 2.2 per 100,000 person-years [3]. Among metformin users with renal function below 60 mL/min/1.73 m2, the adjusted hazard ratio for that outcome was 6.37 (95% CI 1.48 to 27.5) compared with never-users, and it was higher still with large cumulative amounts or a recent high daily dose [3]. A 2016 review put the reported incidence of lactic acidosis in clinical practice at under 10 cases per 100,000 patient-years [4].

## Contrast, surgery and other times the label stops metformin

The label directs stopping metformin at the time of or before an iodinated contrast imaging procedure in patients with eGFR between 30 and 60 mL/min/1.73 m2, in those with a history of hepatic impairment, alcoholism or heart failure, or when intra-arterial iodinated contrast will be used, then re-evaluating eGFR 48 hours afterward and restarting only if renal function is stable [1]. The label states that intravascular iodinated contrast has led to an acute decrease in renal function and lactic acidosis in metformin-treated patients [1].

The label also directs temporary discontinuation while patients have restricted food and fluid intake during surgery or other procedures, and discontinuation when a hypoxic event occurs, such as cardiovascular collapse, acute myocardial infarction or sepsis [1]. Alcohol potentiates metformin's effect on lactate metabolism, and the label warns against excessive intake [1].

## Other monitoring on treatment

Beyond the annual eGFR, the label asks for hematologic parameters every year and [vitamin B12](https://healthrx.com/labs-vitamin-b12/what-it-measures) every 2 to 3 years. Subnormal B12 levels were seen in approximately 7% of patients in 29-week clinical trials [1].

## Does metformin still help at a lower eGFR?

A 2017 systematic review of 17 observational studies found that metformin use was associated with lower all-cause mortality in people with [type 2 diabetes](https://healthrx.com/conditions-type-2-diabetes/diagnosis-algorithm) and moderate to severe CKD, heart failure, or liver disease with hepatic impairment, and with fewer heart failure readmissions in those with CKD or heart failure. The authors rated the strength of evidence low and the studies were observational [5].

Check what you know

Think you have it? Try 3 quick questions and see what the article says.

1. According to the label, is a reduced milligram ceiling attached to the eGFR 30 to 45 range?

Question 1 of 3

Score: 0 right, 0 of 3 answered

Printable lab tracker

Metformin eGFR and kidney test tracker

Use this sheet to record eGFR and kidney test results while taking metformin, note any contrast scans or procedures, and prepare questions for your prescriber or pharmacist. Bring it to kidney test reviews and medication visits.

[Open the fill-in sheet](https://healthrx.com/printables/metformin/renal-impairment) Fill it in, print it or save it as a PDF. No sign-up.

6 videos on Metformin eGFR Dosing Thresholds by Kidney Function

Metformin adjustment in kidney disease

Dr. James Hall | Nephrology Course · Jun 26, 2025 · 6:45

What this video says: Dr. James Hall, a nephrologist, explains that metformin is not directly nephrotoxic but can raise lactate and cause lactic acidosis, with risk rising when kidney function drops. He says he stops metformin when GFR falls below thirty.

Speaking: Dr. James Hall, nephrologist, host of the Nephrology Course channel

[Watch on YouTube](https://www.youtube.com/watch?v=XhRiTym8SlQ)

Metformin & Kidney Failure: What You Need to Know

Dr. James Hall | Nephrology Course · Jul 7, 2025 · 11:11

What this video says: A nephrologist explains that metformin is excreted mostly unchanged by the kidneys, so when kidney function is low it can build up acid and cause lactic acidosis. He says metformin does not itself cause kidney failure, and that he always stops it when GFR is below thirty.

Speaking: Dr. James Hall, nephrologist (Nephrology Course channel)

[Watch on YouTube](https://www.youtube.com/watch?v=W4i3rIN16Tk)

Metformin and Kidney Disease: Safety, history and Efficacy Explained

Kidney Health Made Simple · Feb 14, 2023 · 6:14

What this video says: Dr Hashmi says metformin does not damage or worsen kidney disease. He cites a well-designed study linking it to lower mortality and less dialysis when eGFR is above thirty, and explains that it is avoided below that level because of a very rare risk of lactic acidosis.

Speaking: Dr Hashmi, nephrologist and obesity medicine physician, host of Kidney Health Made Simple

[Watch on YouTube](https://www.youtube.com/watch?v=fR8zWQfeGiI)

Videos checked Nov 13, 2026. Summaries are written from each video's transcript.

Frequently asked questions

At what eGFR is metformin contraindicated?

Below 30 mL/min/1.73 m2. The label lists severe renal impairment as a contraindication and directs discontinuation if eGFR falls below 30 while on treatment [1].

Can metformin be started at an eGFR of 40?

The label says initiation is not recommended at an eGFR between 30 and 45 mL/min/1.73 m2 [1].

My eGFR dropped to 48. Does the label say to stop?

No. The label's reassessment step applies once eGFR falls below 45, when it directs an assessment of benefit and risk of continuing, and discontinuation applies below 30 [1].

Does the label give a lower metformin dose for eGFR 30 to 45?

It gives no reduced milligram target for that range; it addresses whether to start and whether to continue. The labeled maxima of 2,550 mg per day for immediate-release in adults and 2,000 mg once daily for extended-release are unchanged [1][2].

Is metformin stopped for a contrast CT scan?

The label directs stopping at the time of or before the procedure for patients with eGFR 30 to 60 mL/min/1.73 m2, a history of liver disease, alcoholism or heart failure, or intra-arterial contrast, then rechecking eGFR 48 hours later and restarting only if renal function is stable [1].

How often is eGFR checked on metformin?

Before starting and at least once a year in everyone taking it, with more frequent checks in people at risk of renal impairment, such as older adults [1].

Reader questions

What people actually ask

Short answers drawn from the sources this article cites.

Can I take metformin if my eGFR is below 30?

No. The label lists severe renal impairment as a contraindication, and the cutoff is an eGFR below 30 mL/min/1.73 m2. For eGFR 30 to 45, the label says starting is not recommended, and if eGFR later falls below 45 it directs an assessment of the benefit and risk of continuing.

When to withhold metformin eGFR?

The label directs stopping metformin at the time of or before an iodinated contrast imaging procedure for patients with eGFR 30 to 60, a history of hepatic impairment, alcoholism or heart failure, or when intra-arterial contrast is used. It also directs temporary discontinuation during surgery or other procedures with restricted food and fluid intake.

How much metformin should I take?

The labeled maximum is 2,550 mg per day for immediate-release tablets in adults, given in divided doses, and 2,000 mg once daily for extended-release tablets. Immediate-release is titrated up by 500 mg weekly or 850 mg every two weeks, while extended-release is increased by 500 mg weekly and swallowed whole.

When to stop metformin?

The label directs discontinuation if eGFR falls below 30 and immediate discontinuation if lactic acidosis is suspected. It also directs stopping when a hypoxic event occurs, such as cardiovascular collapse, acute myocardial infarction or sepsis.

References

Show all 7 references Hide references

1. U.S. National Library of Medicine, DailyMed. Metformin hydrochloride tablets (Granules, immediate-release) prescribing information. [Metformin hydrochloride tablets (Granules, immediate-release) label](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2387a618-24d8-4813-aa83-9114edb35374)
2. U.S. National Library of Medicine, DailyMed. Metformin hydrochloride extended-release tablets (Sun) prescribing information. [Metformin hydrochloride extended-release tablets (Sun) label](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=41a8bb80-7b0b-476c-8134-5d161c3239c8)
3. Eppenga WL, Lalmohamed A, Geerts AF, Derijks HJ, Wensing M, Egberts A, et al. [Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study](https://pubmed.ncbi.nlm.nih.gov/24842984/). Diabetes Care. 2014;37(8):2218-24.
4. DeFronzo R, Fleming GA, Chen K, Bicsak TA. [Metformin-associated lactic acidosis: Current perspectives on causes and risk](https://pubmed.ncbi.nlm.nih.gov/26773926/). Metabolism. 2016;65(2):20-9.
5. Crowley MJ, Diamantidis CJ, McDuffie JR, Cameron CB, Stanifer JW, Mock CK, et al. [Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review](https://pubmed.ncbi.nlm.nih.gov/28055049/). Ann Intern Med. 2017;166(3):191-200.
6. Reddit participants. [Chronic kidney disease and metformin? (r/diabetes)](https://www.reddit.com/r/diabetes/comments/1t1f3fa/chronic_kidney_disease_and_metformin/). Accessed 2026-11-11.
7. Reddit participants. [Metformin Does Not Cause Kidney Disease (r/diabetes_t2)](https://www.reddit.com/r/diabetes_t2/comments/1qgvsum/metformin_does_not_cause_kidney_disease/). Accessed 2026-11-11.

Next in this cluster

Related reading

- [metformin Metformin eGFR](https://healthrx.com/how-metformin-affects/egfr)
- [metformin Metformin prediabetes evidence](https://healthrx.com/metformin/for-prediabetes)
- [metformin Metformin hepatic impairment](https://healthrx.com/metformin/hepatic-impairment)
- [egfr eGFR test](https://healthrx.com/labs-egfr/when-to-order)
- [metformin Metformin safety signals](https://healthrx.com/metformin/safety-signals-fda)
- [metformin Metformin Seasonal Use Considerations: A Clinical Guide](https://healthrx.com/metformin/seasonal-considerations)
- [metformin Metformin sexual function](https://healthrx.com/metformin/sexual-function-impact)
- [metformin Metformin in Special Populations](https://healthrx.com/metformin/special-populations)
- [metformin Metformin storage](https://healthrx.com/metformin/storage-stability)
- [metformin Switching From or To Metformin](https://healthrx.com/metformin/switching-protocols)
- [metformin Metformin travel](https://healthrx.com/metformin/travel-protocols)
- [metformin Does UnitedHealthcare cover metformin](https://healthrx.com/metformin/unitedhealthcare-coverage)
- [metformin vs lantus Metformin vs lantus side effects](https://healthrx.com/compare-insulin-blood-sugar/metformin-vs-insulin-glargine--side-effects)
- [metformin Can you take metformin with SNRIs](https://healthrx.com/interactions-metformin/with-snri)

![metformin egfr dosing: lab technician handling kidney function samples in a clinical laboratory](https://zwulxpn434zaufgz.public.blob.vercel-storage.com/page-images/metformin/renal-impairment.webp)

Kidney function testing determines the eGFR zone that guides whether metformin can be started, continued or stopped safely. Full metformin dosing renal impairment guide and sources at [healthrx.com/metformin](https://healthrx.com/metformin).

Follow the ingredient research

Explore the publication history, study comparisons and formulations for Metformin.

- [Metformin research](https://healthrx.com/research/ingredients/metformin)
